A new era in cancer therapies is at hand

A new era in cancer therapies is at hand

New therapeutic strategies build on the success of immunotherapy.

Old drugs, new tricks: From aspirin to statins – how repurposed meds can help fight cancers

The potential to ‘repurpose’ familiar drugs to fight cancer rather than pour billions into novel therapies is exciting scientists here and overseas. It’s a...

An immunotherapy trial shows remarkable results in solid tumors. - Charschan Chiropractic in North Brunswick, NJ and Scotch Plains, NJ

When patients were diagnosed with certain types of tumors or cancers, part of the cure may have been a surgery or a treatment that may have been horrible. An immunotherapy trial performed by Memorial Sloan Kettering Cancer Center may offer better cures without the trauma or disfiguring surgeries. Oncologists regularly treat solid tumors in the stomach, esophagus, or rectum with surgeries that may include removal of the stomach, permanent colosto…

A new era in cancer therapies is at hand - WorldNL Magazine

New therapeutic strategies build on the success of immunotherapy. In 2012, clinicians at the Children’s Hospital of Philadelphia treated Emily Whitehead, a 6-year-old with leukemia, with altered immune cells from her own body. At the time, the treatment was experimental, but it worked: The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. The modified cells, called CAR-T cells, are a form of immun…

A new study by the National Center for Oncological Research (CNIO), in Spain, could radically change the way colon cancer is being combated.The team led by Dr. Nabil Djouder, head of the CNIO Group of Growth Factors, Nutrients and Cancer, managed to identify a molecular mechanism that allows colorectal tumors to develop.The finding, published in the prestigious scientific journal Nature Communications, reveals that the loss of a key protein - th…

New anti -cancer molecules kill stronger sick cells - Global Happenings

A new class of anti-cancer molecules is capable of kill sick cells more resistant to therapies and which often give rise to metastases. Their success is due to the ability to weaken cancer cells take advantage of the iron which accumulate in large quantities. The result, published in the magazine Nature, is due to the research group led by the French Institute Curie, the National Center for Scientific Research (CNRS) and the French National Inst…